HelioLiver LDT now available to order through Quest Diagnostics
A life sciences team collaborating on innovation strategy with sticky notes
News & Media

PM360 Announces Selections for 11th Annual Innovations Issue

Recognition December 2022 5 min read PM360
Share

HelioLiver was named to PM360’s 11th Annual Innovations Issue — the trade magazine’s guide to the year’s most groundbreaking advancements in life sciences and healthcare — selected in the Products category.

HelioLiver collection kit box
HelioLiver
Selected in the Products category

News provided by PM360. Published on PR Newswire.

HelioLiver (Helio Genomics) was selected in the Products category of PM360’s 11th Annual Innovations Issue.

While innovation has always been the lifeblood of the life sciences industry, companies in this sector had to put their innovative efforts into overdrive during the pandemic to move faster than ever before to develop new treatments, vaccines, and other solutions. But, three years later companies aren’t slowing down as they work to revamp, reimagine, and just flat out improve all facets of how the industry operates from development to commercialization, marketing, market access, and much more. PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, once again aims to highlight the most groundbreaking of these efforts in its annual Innovations Issue.

For the past 11 years, PM360’s Innovations Issue has served as the preeminent guide to the past year’s cutting-edge advancements and innovations from within life sciences and healthcare. The issue examines innovations and innovators within six categories: Companies, Startups, Divisions, Products, Services, and Strategies. This year, PM360 received hundreds of submissions from across the healthcare and life sciences industries, and the PM360 editorial staff selected the very best in each category — totaling 46 selections.

“The industry’s accomplishments during the pandemic have been extraordinary, but innovation is always at the very core of the life sciences and we can expect many more exciting developments in the near future. Among this year’s selections alone, you can find advancements being made in gene editing, RNA therapies, and cancer diagnostic technology; solutions to improve targeting techniques in marketing, meal preparation during clinical trials, and tracking products along the supply chain; and new approaches to medical education, behavioral science, and even TikTok. Because our industry is always thinking bigger as it works to improve each and every facet that impacts its ultimate goal of helping patients in need.”

ASAnna StashowerCEO, Publisher & Editor-in-Chief, PM360

The Innovations Issue was published in PM360’s December issue, and the profiles can be found online at pm360online.com/pm360-presents-the-2022-innovators.

The 2022 PM360 Innovations Issue Selections

Companies

  • Cluep
  • CMI Media Group
  • Confideo Labs
  • FundamentalVR
  • Impel Pharmaceuticals, Inc.
  • Sharecare

Divisions

  • Advanced Therapy Solutions (Cardinal Health)
  • BCW WHY (BCW Global)
  • Cramer Health (Cramer)
  • Vitamin MD (Calcium)

Products

  • Aidia System Smart Cap (AdhereTech)
  • Anura Contactless Health Monitoring Platform (NuraLogix)
  • Audience Marketplace (DeepIntent)
  • Clinical Cuisine™ (BBK Worldwide)
  • DOL Map (PRECISIONscientia)
  • HelioLiver (Helio Genomics)
  • InCrowd Essentials (InCrowd, Inc., member of the Apollo Intelligence family of companies)
  • KOL Select Video Engagement Platform (Bionical Solutions)
  • Medidata Link (Medidata)
  • MX# Identity Resolution (Medicx Health)
  • SmartBrochure and Counter Display with Wireless Charging (Vpak Media)
  • Veeva Crossix HCP Trigger Data (Veeva Systems)
  • Wellkind, the Patient App (VMS BioMarketing)
  • What Unites Us (Condé Nast)
  • Withings RPM (Withings Health Solutions)
  • ZING Engagement Suite (P360)

Services

  • BloqBridge (Bloqcube)
  • Discontinuation Report (Amplity Health)
  • Enterprise Data Platform (ConnectiveRx)
  • Influencer Marketing (Health Union)
  • PatientMetRx (Talking Medicines)
  • Virtual Learning Programs (Impetus Digital)

Startups

  • Ascidian Therapeutics
  • Cellarity
  • conversationHEALTH
  • Hot Iron Health
  • Senda Biosciences
  • Spesana
  • Stratipath
  • XpertPatient LLC

Strategies

  • Commercial Acceleration (Rebound)
  • Corporate Branded TikTok (Amgen & imre Health)
  • Direct-to-Patient Care Model (EVERSANA)
  • Enabling Privacy and Personalization in Health Advertising (Publicis Health Media & Meta)
  • HS Resource Center (UCB and MyHealthTeam)
  • Predictive Analytics Drives Coverage Gap Awareness at Point of Care (OptimizeRx)

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

Read the Press Release

News provided by PM360. View source version on PR Newswire.

Related Articles

More from Helio Genomics

NewsMay 12, 2026

HelioLiver Expands Access Through Quest

Helio broadens access to HelioLiver through Quest Diagnostics’ nationwide network of patient service centers.

Read more
NewsMay 8, 2026

Collaborating with the Rural Health Transformation Collaborative, Co-Chaired by Microsoft

Helio joins the Rural Health Transformation Collaborative, co-chaired by Microsoft, to expand rural early detection.

Read more
VoicesMay 6, 2026

Bharat Tewarie: Giving Patients a “Real Fighting Chance” Against Liver Cancer

Helio’s CEO reflects on the landmark CLiMB study and what earlier liver cancer detection means for patients.

Read more